Ricardo Pardal

Dr. Ricardo Pardal

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2003 in Nature Reviews Cancer
Verified
Journal Article
Closed access
RPRicardo Pardal
Ricardo Pardal
MCMichael F. Clarke
Michael F. Clarke
SMSean J. Morrison
Sean J. Morrison

12 October 2003 in Nature
Verified
Journal Article
Closed access
PDF file
MDManuel Alvarez Dolado
Manuel Alvarez Dolado
RPRicardo Pardal
Ricardo Pardal
JGJose Manuel García-Verdugo
Jose Manuel García-Verdugo
JFJohn R. Fike
John R. Fike
HLHyun O. Lee
Hyun O. Lee
AAArturo Alvarez-Buylla
Arturo Alvarez-Buylla

22 October 2003 in Nature
Verified
Journal Article
Closed access
PDF file
AMAnna V. Molofsky
Anna V. Molofsky
RPRicardo Pardal
Ricardo Pardal
TIToshihide Iwashita
Toshihide Iwashita
IPIn-Kyung Park
In-Kyung Park
MCMichael F. Clarke
Michael F. Clarke
SMSean J. Morrison
Sean J. Morrison

6 September 2006 in Nature
Verified
Journal Article
Closed access
PDF file
AMAnna V. Molofsky
Anna V. Molofsky
SSShalom G. Slutsky
Shalom G. Slutsky
NJNancy M. Joseph
Nancy M. Joseph
SHShenghui He
Shenghui He
RPRicardo Pardal
Ricardo Pardal
SMSean J. Morrison
Sean J. Morrison

15 June 2005 in Genes & Development
Verified
Journal Article
Open access
PDF file
AMAnna V. Molofsky
Anna V. Molofsky
SHShenghui He
Shenghui He
MBMohammad Bydon
Mohammad Bydon
SMSean J. Morrison
Sean J. Morrison
RPRicardo Pardal
Ricardo Pardal
Bmi-1 is required for the post-natal maintenance of stem cells in multiple tissues including the central nervous system (CNS) and peripheral nervous system (PNS). Deletion of Ink4a or Arf from Bmi-1-/- mice partially rescued stem cell self-renewal and stem cell frequency in the CNS and PNS, as well as forebrain proliferation and gut neurogenesis. Arf deficiency, but not Ink4a deficiency, partially rescued cerebellum development, demonstrating regional differences in the sensitivity of progenitors to p16Ink4a and p19Arf. Deletion of both Ink4a and Arf did not affect the growth or survival of Bmi-1-/- mice or completely rescue neural development. Bmi-1 thus prevents the premature senescence of neural stem cells by repressing Ink4a and Arf, but additional pathways must also function downstream of Bmi-1.

1 March 2001 in Annual Review of Physiology
Verified
Journal Article
Closed access
JLJosé López-Barneo
José López-Barneo
RPRicardo Pardal
Ricardo Pardal
POPatricia Ortega-Sáenz
Patricia Ortega-Sáenz
▪ Abstract O2sensing is a fundamental biological process necessary for adaptation of living organisms to variable habitats and physiological situations. Cellular responses to hypoxia can be acute or chronic. Acute responses rely mainly on O2-regulated ion channels, which mediate adaptive changes in cell excitability, contractility, and secretory activity. Chronic responses depend on the modulation of hypoxia-inducible transcription factors, which determine the expression of numerous genes encoding enzymes, transporters and growth factors. O2-regulated ion channels and transcription factors are part of a widely operating signaling system that helps provide sufficient O2to the tissues and protect the cells against damage due to O2deficiency. Despite recent advances in the molecular characterization of O2-regulated ion channels and hypoxia-inducible factors, several unanswered questions remain regarding the nature of the O2sensor molecules and the mechanisms of interaction between the sensors and the effectors. Current models of O2sensing are based on either a heme protein capable of reversibly binding O2or the production of oxygen reactive species by NAD(P)H oxidases and mitochondria. Complete molecular characterization of the hypoxia signaling pathways will help elucidate the differential sensitivity to hypoxia of the various cell types and the gradation of the cellular responses to variable levels of PO2. A deeper understanding of the cellular mechanisms of O2sensing will facilitate the development of new pharmacological tools effective in the treatment of diseases such as stroke or myocardial ischemia caused by localized deficits of O2.